No Data
H.C. Wainwright Maintains Enlivex Therapeutics(ENLV.US) With Buy Rating, Maintains Target Price $6
All You Need to Know About Enlivex Therapeutics (ENLV) Rating Upgrade to Buy
H.C. Wainwright Maintains Enlivex Therapeutics(ENLV.US) With Buy Rating, Maintains Target Price $6
H.C. Wainwright analyst Ram Selvaraju maintains $Enlivex Therapeutics(ENLV.US)$ with a buy rating, and maintains the target price at $6.According to TipRanks data, the analyst has a success rate of 40
Enlivex Therapeutics Financials Indicate Net Loss
Enlivex Therapeutics Price Target Announced at $13.00/Share by EF Hutton
EF Hutton Initiates Coverage On Enlivex Therapeutics With Buy Rating, Announces Price Target of $13